NCT07210515: Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
- State
- Under way
- Phase
- Phase 3
- People
- 270 planned
- Started
- 14 Apr 2026
- Primary completion
- Dec 2027
- Arms
- neridronate
- Results
- None posted
- 7 Oct 2025: Trial registered
- 14 Apr 2026: Trial started